日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Accessibility of Biologic Drugs in Morocco: Comparison with FDA and EMA Approvals (2015-2025)

摩洛哥生物制剂的可及性:与FDA和EMA批准情况的比较(2015-2025年)

Charrak, Mounir; Cherrah, Yahia; Serragui, Samira

[Traditional camphor misuse: a forgotten danger to children (about 2 cases)]

【传统樟脑滥用:对儿童的被遗忘的危险(约2例)】

Nchinech, Naoual; Elgharbi, Afaf; Aglili, Fatima Zahra; Kriouile, Yamna; Cherrah, Yahia; Mdaghri, Asmaa Aaloui; Serragui, Samira

National strategy for the integration of pharmacovigilance in the Moroccan TB Control Program

摩洛哥结核病控制规划中药物警戒整合的国家战略

Tanani, Driss Soussi; Serragui, Samira; Hammi, Sanae; Moussa, Latifa Ait; Soulaymani, Abdelmajid; Soulaymani, Rachida; Cherrah, Yahia

Rifampicin and isoniazid plasma concentrations in relation to adverse reactions in tuberculosis patients: a retrospective analysis

利福平和异烟肼血浆浓度与结核病患者不良反应的关系:一项回顾性分析

Aït Moussa, L; El Bouazzi, O; Serragui, S; Soussi Tanani, D; Soulaymani, A; Soulaymani, R

[Therapeutic drug monitoring of three antiepileptic drugs - Back on twenty years of experience]

【三种抗癫痫药物的治疗药物监测——回顾二十年的经验】

Serragui, Samira; Zalagh, Fatima; Tanani, Driss Soussi; Ouammi, Lahcen; Moussa, Latifa Ait; Badrane, Narjis; Bencheikh, Rachida Soulaymani